Use Advanced Search Facility
Protein transformations that change lives
Sequencing
Reagents
DUB
Skip to main content
Home
About Us
Drug Discovery
Quality Control
Services
Premier Screen
Express Screen
Lipid Kinase Screen
IC50 Determination
ATP Competition Assay
Substrate Screen
Custom Screening
Inhibitor Data
FAQ
Contact Us
Inhibitor | Vandetanib
Compound name
Brutto
MW
CAS
PubChem CID
Action
Reference
Reference
Vandetanib
C
22
H
24
BrFN
4
O
2
443913-73-3
3081361
Multiple Tyrosine kinases targeted
Screening Results Chart
Screening Results Tables
